COMPARISON OF GLECAPREVIR/PIBRENTASVIR AND SOFOSBUVIR/LEDIPASVIR AS PANGENOTYPIC DAA IN PATIENTS WITH CHRONIC HEPATITIS C IN SOUTH KOREA: MULTICENTER STUDY

被引：0

作者：

Kim, SukBae ^{[1
,2
]}

Song, Han, II ^{[3
]}

Lee, Sae Hwan ^{[4
,5
]}

Kim, Hong Soo, II ^{[5
]}

Lee, Tae Hee ^{[6
,7
]}

Soo, Eun Hyuk ^{[8
]}

Kim, Seok Hyun ^{[9
]}

Lee, Byung Seok ^{[10
]}

Chae, Hee Bok ^{[11
]}

Song, Myeong Jun ^{[12
]}

Ko, Soon Young ^{[13
]}

机构：

[1] Dankook Univ Coll Med, Yongin, South Korea

[2] Dankook Univ Hosp, Dankook Univ Coll Med, Dept Internal Med, Cheonan, South Korea

[3] Dankook Univ Hosp, Cheonan, South Korea

[4] Soonchunhyang Univ, Asan, South Korea

[5] Soonchunhyang Univ Cheonan Hosp, Gastroenterol, Cheonan, South Korea

[6] Konyang Univ Coll Med, Dept Internal Med, Nonsan, South Korea

[7] Konyang Univ Hosp, Daejeon, South Korea

[8] Chungnam Natl Univ, Sch Med, Dept Internal Med, Munhwa Ro, 282 Munhwa-Ro, Daejeon 35015, South Korea

[9] Chungnam Natl Univ Hosp, Dept Gastroenterol, 282 Munhwa-Ro, Daejeon 35015, South Korea

[10] Chungnam Natl Univ Hosp, Dept Gastroenterol, Daejeon, South Korea

[11] Chungbuk Natl Univ Hosp, Chungbuk Natl Univ Coll Med, Dept Internal Med, Cheongju, South Korea

[12] Catholic Univ Coll Med, Seoul, South Korea

[13] Konkuk Univ Coll Med, Seoul, South Korea

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1295

引用

页码：S386 / S386

页数：1

共 50 条

[21] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
Akito Nozaki
Masanori Atsukawa
Chisa Kondo
Hidenori Toyoda
Makoto Chuma
Makoto Nakamuta
Haruki Uojima
Koichi Takaguchi
Hiroki Ikeda
Tsunamasa Watanabe
Shintaro Ogawa
Norio Itokawa
Taeang Arai
Atsushi Hiraoka
Toru Asano
Shinichi Fujioka
Tadashi Ikegami
Toshihide Shima
Chikara Ogawa
Takehiro Akahane
Noritomo Shimada
Shinya Fukunishi
Hiroshi Abe
Akihito Tsubota
Takuya Genda
Hironao Okubo
Shigeru Mikami
Asahiro Morishita
Akio Moriya
Joji Tani
Yoshihiko Tachi
Naoki Hotta
Toru Ishikawa
Takeshi Okanoue
Yasuhito Tanaka
Takashi Kumada
Katsuhiko Iwakiri
Shin Maeda
Hepatology International, 2020, 14 : 225 - 238
[22] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
Nozaki, Akito
Atsukawa, Masanori
Kondo, Chisa
Toyoda, Hidenori
Chuma, Makoto
Nakamuta, Makoto
Uojima, Haruki
Takaguchi, Koichi
Ikeda, Hiroki
Watanabe, Tsunamasa
Ogawa, Shintaro
Itokawa, Norio
Arai, Taeang
Hiraoka, Atsushi
Asano, Toru
Fujioka, Shinichi
Ikegami, Tadashi
Shima, Toshihide
Ogawa, Chikara
Akahane, Takehiro
Shimada, Noritomo
Fukunishi, Shinya
Abe, Hiroshi
Tsubota, Akihito
Genda, Takuya
Okubo, Hironao
Mikami, Shigeru
Morishita, Asahiro
Moriya, Akio
Tani, Joji
Tachi, Yoshihiko
Hotta, Naoki
Ishikawa, Toru
Okanoue, Takeshi
Tanaka, Yasuhito
Kumada, Takashi
Iwakiri, Katsuhiko
Maeda, Shin
HEPATOLOGY INTERNATIONAL, 2020, 14 (02) : 225 - 238
[23] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Mizuochi, Tatsuki
Iwama, Itaru
Inui, Ayano
Ito, Yoshinori
Takaki, Yugo
Mushiake, Sotaro
Tokuhara, Daisuke
Ishige, Takashi
Ito, Koichi
Murakami, Jun
Hishiki, Haruka
Mikami, Hitoshi
Bessho, Kazuhiko
Kato, Ken
Yasuda, Ryosuke
Yamashita, Yushiro
Tanaka, Yasuhito
Tajiri, Hitoshi
JOURNAL OF GASTROENTEROLOGY, 2023, 58 (04) : 405 - 412
[24] Efficacy and safety of glecaprevir/pibrentasvir treatment in Koreans with chronic hepatitis C: A retrospective study
Kwan, Byung Soo
Kong, Sung Min
Shim, Sang Goon
Kim, Kwang Min
Yu, Gil Jong
Lee, Jae Jin
Kim, Jin Dong
ARAB JOURNAL OF GASTROENTEROLOGY, 2023, 24 (02) : 104 - 108
[25] Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
Abdelaty, Lamiaa N.
Elnaggar, Ahmed A.
Said, Amira A.
Hussein, Raghda R. S.
CURRENT DRUG SAFETY, 2020, 15 (01) : 53 - 60
[26] Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter Study
Stinco, Mariangela
Rubino, Chiara
Bartolini, Elisa
Nuti, Federica
Paolella, Giulia
Nebbia, Gabriella
Silvestro, Erika
Garazzino, Silvia
Nicastro, Emanuele
D'Antiga, Lorenzo
Zanchi, Chiara
Morra, Laura
Iorio, Raffaele
Di Dato, Fabiola
Maggiore, Giuseppe
Sartorelli, Maria Rita
Comparcola, Donatella
Stracuzzi, Marta
Giacomet, Vania
Musto, Francesca
Pinon, Michele
Calvo, Pierluigi
Carloni, Ines
Zallocco, Federica
Cananzi, Mara
Trapani, Sandra
Indolfi, Giuseppe
LIVER INTERNATIONAL, 2025, 45 (04)
[27] Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
Walsh, C. E.
Workowski, K.
Terrault, N. A.
Sax, P. E.
Cohen, A.
Bowlus, C. L.
Kim, A. Y.
Hyland, R. H.
Han, B.
Wang, J.
Stamm, L. M.
Brainard, D. M.
McHutchison, J. G.
von Drygalski, A.
Rhame, F.
Fried, M. W.
Kouides, P.
Balba, G.
Reddy, K. R.
HAEMOPHILIA, 2017, 23 (02) : 198 - 206
[28] Hepatitis B reactivation in chronic hepatitis C patients during treatment with ledipasvir and sofosbuvir
Ou, Pengcheng
Chen, Jun
ANTIVIRAL THERAPY, 2018, 23 (03) : 283 - 284
[29] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
Liu, Chen-Hua
Yang, Sheng-Shun
Peng, Cheng-Yuan
Lin, Woan-Tyy
Liu, Chun-Jen
Su, Tung-Hung
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
JOURNAL OF VIRAL HEPATITIS, 2020, 27 (06) : 568 - 575
[30] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Tatsuki Mizuochi
Itaru Iwama
Ayano Inui
Yoshinori Ito
Yugo Takaki
Sotaro Mushiake
Daisuke Tokuhara
Takashi Ishige
Koichi Ito
Jun Murakami
Haruka Hishiki
Hitoshi Mikami
Kazuhiko Bessho
Ken Kato
Ryosuke Yasuda
Yushiro Yamashita
Yasuhito Tanaka
Hitoshi Tajiri
Journal of Gastroenterology, 2023, 58 : 405 - 412

← 1 2 3 4 5 →